Amendment119th Congress
An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.
- Amendment Number
- 23
- Description
- An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.
- Congress
- 119
- Type
- HAMDT
- Latest Action Date
- Jun 4, 2025
- Latest Action Text
- On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.
- Latest Action Time
- 15:08:05
- Submitted Date
- Jun 4, 2025
- Chamber
- House of Representatives
- Update Date
- Jun 5, 2025